Streetbeat News

Products Services

EWY

The iShares MSCI South Korea ETF (EWY) is facing bearish sentiment due to geopolitical tensions and a strong US Dollar. Despite its attractive valuation, EWY's significant exposure to Samsung Electronics and SK hynix, along with a high concentration in IT, increases its risk. Technical analysis shows bearish momentum with key support levels at $55 and $47-$48, indicating potential buying opportunities.

Portfolio Pulse from

November 15, 2024 | 8:00 am

BVNKF

Bavarian Nordic has announced that it has secured orders worth $340 million for its mpox and smallpox vaccine, to be delivered in 2025. This includes previously announced deferred revenue.

Portfolio Pulse from

November 15, 2024 | 8:00 am

BNO

Geopolitical tensions and weak Chinese demand are negatively impacting natural gas and oil prices. Technical indicators suggest a bearish market momentum, raising concerns about price recovery.

Portfolio Pulse from

November 15, 2024 | 7:30 am

ANPCY

ANGLE plc has announced the presentation of new data on its Parsortix-based PD-L1 assay at the AACR conference. This assay allows for the monitoring of PD-L1 status in lung cancer patients, potentially advancing personalized treatment.

Portfolio Pulse from

November 15, 2024 | 7:15 am

ANPCY

ANGLE plc announced the development of a Parsortix-based HER2 assay kit, showcased at the AACR conference. This kit aims to provide an optimized solution for assessing HER2 status in breast cancer, with progress reported in collaboration with BioView.

Portfolio Pulse from

November 15, 2024 | 7:15 am

BWEFF

BW Energy reported strong third-quarter results for 2024, with an EBITDA of USD 130 million and a net profit of USD 48 million. The company achieved record operational cash flow and production levels, particularly from the Dussafu license in Gabon. BW Energy is on track to complete ESP change-outs in Gabon by year-end and has finalized agreements for exploration blocks offshore Gabon.

Portfolio Pulse from

November 15, 2024 | 6:45 am

BWOFY

BW Offshore reported its third quarter 2024 results, highlighting an EBITDA of USD 83 million and a net profit of USD 13 million. The company declared a cash dividend of USD 0.0625 per share. The Barossa FPSO project is 90% complete, with full-year EBITDA expectations increased to USD 315-320 million.

Portfolio Pulse from

November 15, 2024 | 6:45 am

BP

EQNR

SHEL

TTE

TotalEnergies, BP, Shell, and Equinor have announced a $500 million joint investment to enhance access to sustainable modern energy sources.

Portfolio Pulse from

November 15, 2024 | 6:30 am

SDZNY

Sandoz has received European Commission approval for Afqlir® (aflibercept), a biosimilar to Eylea®, to treat retinal diseases. This strengthens Sandoz's biosimilar portfolio and reinforces its leadership in the global and European markets.

Portfolio Pulse from

November 15, 2024 | 6:15 am

REGN

Regeneron Pharmaceuticals and Sanofi announced that the FDA has accepted the resubmission of the sBLA for Dupixent to treat chronic spontaneous urticaria (CSU). If approved, it would be the first targeted therapy for CSU in a decade, with a decision expected by April 18, 2025.

Portfolio Pulse from

November 15, 2024 | 6:15 am